News

Get in touch

Remynd is located in the Arenberg Science Park, a hub of innovation and research. Our labs and offices are situated in the Bio Incubator 3 building.

Press releases & papers

04/03/2025

Press release

remynd strenghtens drug development focus with strategic sale of CRO business to InnoSer

30/10/2024

Press release

remynd announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease

03/09/2024

Press release

remynd appoints new CEO and Chairman to progress novel Alzheimer’s Disease program through clinical development

31/05/2024

Paper

Pharmacological modulation of septins

restores calcium homeostasis and is neuroprotective in models of Alzheimer’s disease